ReviewInternational journal of molecular sciences2020

From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma.

Christopher Montemagno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.